Posts
Kidney cancer rarely affects children. The most common one is Wilms’ tumor, also called nephroblastoma, that accounts for up to 95% of childhood kidney cancers, with most children being below the age of 5 years. It is a fast growing tumor that can spread (metastasize). It is usually treated by surgery, followed by radiation and chemotherapy. Commonly used chemo drugs are doxorubicin, vincristine and actinomycin D. Overall survival rates tend to be high (>90%), with favourable histopathology diagnosis and timely treatment.
/0 Comments/in Blog /by adminSeptember is Childhood Cancer Awareness Month. 30,000 children in India and 10 times that number worldwide develop cancer every year. There is a lack of awareness and timely diagnosis to treat them. Sapien will be sharing the Indian cancer data it has throughout September, starting with colorectal cancer.
/0 Comments/in Blog /by adminRejig.HydStartups kick-off G.R.O.W
/0 Comments/in Blog /by admin
First of the Rejig.Hyderabad marathon sessions happened yesterday evening. A total of 13 companies, broadly in area of healthcare, were given 3 minutes each to pitch virtually in front of 4 mentors: @Ambuj Chaturvedi, @Vijay Bhaskar, @Neetika Maheshwari, @Vivek Bhargava, with @Paridhi Gupta and @Ramjee Pallela diligently keeping us all on time. It was heartening to get instant mentor feedback to our pitch for growth funds in that they all said Sapien had clearly proven traction and market validation for its services and products. They were keen to see our roadmap for scale-up, product and IP potential, and interested in seeing how the structured patient data we have built up carefully for breast, lung, renal, colorectal, gliomas etc. could be made available for research at universities to build data analytics & AI capabilities. I look forward to the 1-on-1 mentoring sessions to help refine our pitch for success.
To contact us – please write to queries@sapienbio.com
Locate Us
Sapien Biosciences,
1st Floor, AIMSR Building,
Apollo Health City,
Jubilee Hills,
Hyderabad 500 096
Phone:
+91-99859 25652
+91-73863 01984
Email:
info@sapienbio.com
queries@sapienbio.com
Recent Posts
- Dr. Jugnu Jain, CEO, delivering an invited talk on “Sustainability of Biobanking in India” at the workshop on Biobanking organized by ILBS, New Delhi.
- Quatramer’s tunability stems from the fact that the system can be modified and adjusted to deliver single or multiple ratios of payloads in order to optimize synergistic mechanisms of action in lower doses.
- Our paper is out in Frontiers in Pharmacology
- Sapien’s work for Hillstream BioPharma presented at AACR
- Dr. Jugnu Jain shares her thoughts on entrepreneurship with the T-Hub Hyderabad
Recent Comments